Sign of Leser-Trelat: a paraneoplastic sign of internal malignancy
DOI:
https://doi.org/10.66344/jpad.v26i1.78Keywords:
Seborrhoeic keratosis, breast carcinomaAbstract
A 63-year-old female presented with dark brown hyperpigmented macules and slightly elevated papules all over body, clinically and histopathologically suggestive of seborrhoeic keratosis. She was diagnosed as breast carcinoma 5 years back and got mastectomy done 2 years back. Cutaneous lesions appeared 6 months before the diagnosis of breast carcinoma and remained static after mastectomy, thus fulfilling some of the Curth’s criteria for the diagnosis of paraneoplastic syndrome. Till date there is only one report of Leser-Trelat sign with associated carcinoma of breast. We are reporting Leser-Trelat as a paraneoplastic phenomenon secondary to invasive ductal breast carcinoma for its rarity and the classical clinicopathological evidence.
References
1. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143:854-9.
2. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood. 2000;95:2937-42.
3. Lynch HT, Fusaro RM, Pester JA, Lynch JF. Leser-Trelat sign in mother and daughter with breast cancer. J Med Genet. 1982;19:218-21.
4. Lee CH, Clark AR, Thorpe ME et al. Bile duct adenocarcinoma with Leser-Trelat sign and pure red blood cell aplasia. Cancer. 1980;46:1657-60.
Published
Issue
Section
License
Copyright (c) 2016 S.V. Choudhary, S. A. Bhattar, A.L. Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
